TrialBlood cancer journal2017

A phase 1/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia.

G L Uy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.